Post-Authorization Safety Study of OZURDEX® (Dexamethasone Intravitreal Implant): A Prospective Observational Study to Evaluate Long-Term Safety in Real-World Clinical Practice (CONSTANCE)

13/09/2016
14/03/2024
EU PAS number:
EUPAS15160
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Allergan_Ozurdex_PASS_protocol_17Jan2012_v1.6_Final_signed_Redacted

English (256.12 KB - PDF) View document
Study results
Study results

Allergan_Ozurdex_PASS_Abstract_Redacted

English (682.66 KB - PDF) View document
Study report
Other information